Search Results for "Contrave"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Contrave. Results 1 to 3 of 3 total matches.
Comparison Table: Some Drugs for Weight Management (online only)
The Medical Letter on Drugs and Therapeutics • Aug 04, 2025 (Issue 1734)
Naltrexone/bupropion – Contrave
(Currax)
8/90 mg ER tabs 16/180 mg PO bid
Titration: 1 tablet qAM in
week ...
View the Comparison Table: Some Drugs for Weight Management
Med Lett Drugs Ther. 2025 Aug 4;67(1734):e127-30 doi:10.58347/tml.2025.1734b | Show Introduction Hide Introduction
Dextromethorphan/Bupropion (Auvelity) for Depression
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022 (Issue 1666)
(Contrave) is
approved for weight management.
PHARMACOLOGY — Dextromethorphan is an analog
of the opioid ...
The FDA has approved an extended-release fixed-dose
combination of dextromethorphan and
bupropion (Auvelity – Axsome) for treatment of major
depressive disorder (MDD) in adults.
Drugs and Devices for Weight Management
The Medical Letter on Drugs and Therapeutics • Aug 04, 2025 (Issue 1734)
Naltrexone/bupropion – Contrave (Currax) 8/90 mg ER tabs 16/180 mg PO bid13 2-4%/31-54% 625.20
Lipase ...
Overweight is generally defined as a body mass
index (BMI) between 25 and 29.9 kg/m2 in adults. A
BMI ≥30 is considered obese (criteria differ slightly in
Asian patients). In patients with an elevated BMI, a
5-10% reduction in weight has been associated with
a reduction in the risk of developing type 2 diabetes,
hypertension, and dyslipidemia. Diet, exercise, and
behavior modification are the traditional methods
for losing weight, but they are often inadequate; the
American College of Cardiology no longer recommends
that all patients try lifestyle modification alone before
adding...
Med Lett Drugs Ther. 2025 Aug 4;67(1734):121-8 doi:10.58347/tml.2025.1734a | Show Introduction Hide Introduction
